cyclopentane has been researched along with Critical Illness in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chopra, A; Cies, JJ; Enache, A; Moore, WS | 1 |
| Louie, JK; Samuel, MC; Schechter, R; Uyeki, TM; Yang, S | 1 |
| Choi, SH; Hong, SB; Huh, JW; Koh, Y; Lim, CM; Yoo, JW | 1 |
| Makino, H; Nasu, T; Ogawa, D; Wada, J | 1 |
| Adiga, R; Armstrong, R; Bazan, J; Bonilla, H; Bradley, J; Dretler, R; Elder, J; Hernandez, JE; Hollister, AS; Ison, MG; Mangino, JE; Maroushek, S; Sheridan, W; Shetty, AK; Wald, A; Ziebold, C | 1 |
| Acosta, M; Louie, JK; Schechter, R; Uyeki, TM; Yang, S; Yen, C | 1 |
6 other study(ies) available for cyclopentane and Critical Illness
| Article | Year |
|---|---|
Peramivir for Influenza A and B Viral Infections: A Pharmacokinetic Case Series.
Topics: Acids, Carbocyclic; Antiviral Agents; Child; Child, Preschool; Cohort Studies; Critical Illness; Cyclopentanes; Drug Administration Schedule; Female; Guanidines; Half-Life; Hospitalization; Humans; Infant; Influenza A virus; Influenza B virus; Influenza, Human; Intensive Care Units, Pediatric; Male; Retrospective Studies; Tissue Distribution | 2019 |
Neuraminidase inhibitors for critically ill children with influenza.
Topics: Acids, Carbocyclic; Adolescent; Betainfluenzavirus; California; Child; Child, Preschool; Critical Care; Critical Illness; Cyclopentanes; Drug Administration Schedule; Enzyme Inhibitors; Guanidines; Hospitalization; Humans; Infant; Infant, Newborn; Influenza A Virus, H1N1 Subtype; Influenza, Human; Logistic Models; Multivariate Analysis; Neuraminidase; Odds Ratio; Oseltamivir; Pandemics; Population Surveillance; Treatment Outcome; Zanamivir | 2013 |
Peramivir is as effective as oral oseltamivir in the treatment of severe seasonal influenza.
Topics: Acids, Carbocyclic; Administration, Oral; Adult; Aged; Aged, 80 and over; Antiviral Agents; Critical Illness; Cyclopentanes; Guanidines; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Intensive Care Units; Length of Stay; Middle Aged; Organ Dysfunction Scores; Oseltamivir; Retrospective Studies; Seasons; Time Factors; Treatment Outcome; Young Adult | 2015 |
Peramivir for severe influenza infection in a patient with diabetic nephropathy.
Topics: Acids, Carbocyclic; C-Reactive Protein; Critical Illness; Cyclopentanes; Diabetic Nephropathies; Female; Guanidines; Humans; Influenza A virus; Influenza, Human; Middle Aged; Neuraminidase; Respiratory Insufficiency | 2010 |
Clinical experience in adults and children treated with intravenous peramivir for 2009 influenza A (H1N1) under an Emergency IND program in the United States.
Topics: Acids, Carbocyclic; Adolescent; Adult; Aged; Antiviral Agents; Child; Child, Preschool; Critical Illness; Cyclopentanes; Drugs, Investigational; Female; Guanidines; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Pregnancy; Survival Analysis; Treatment Outcome; United States; Young Adult | 2011 |
Use of intravenous peramivir for treatment of severe influenza A(H1N1)pdm09.
Topics: Acids, Carbocyclic; Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; California; Child; Child, Preschool; Critical Illness; Cyclopentanes; Female; Guanidines; Humans; Infant; Infant, Newborn; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Pandemics; Retrospective Studies; Severity of Illness Index; Young Adult | 2012 |